BECTON, DICKINSON AND COMPANY Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months
BECTON, DICKINSON AND COMPANY (BDX) reported Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months of $39.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY cash flow hedge gain (loss) to be reclassified within twelve months for the quarter ending 2026-06-30 was $6.00M.
- BECTON, DICKINSON AND COMPANY cash flow hedge gain (loss) to be reclassified within twelve months for the quarter ending 2026-03-31 was $1.00M.
- BECTON, DICKINSON AND COMPANY cash flow hedge gain (loss) to be reclassified within twelve months for the quarter ending 2025-12-31 was $32.00M.
| Period end | Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months 3 month | Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months 6 month | Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months 9 month |
|---|---|---|---|
| 2026-06-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $7.00M derived: sum of 2 quarters · filed 2026-08-06 | $39.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $33.00M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $32.00M 10-Q · filed 2026-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |